Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US16773720Application Date: 2020-01-27
-
Publication No.: US10975043B2Publication Date: 2021-04-13
- Inventor: Yoshihiro Banno , Masahiro Kamaura , Kazuaki Takami , Koichiro Fukuda , Shigekazu Sasaki
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Haug Partners LLP
- Agent Jon E. Gordon
- Priority: JP2014-217770 20141024
- Main IPC: A61K31/4418
- IPC: A61K31/4418 ; A61K31/505 ; C07D239/34 ; C07D213/65 ; C07D213/70 ; C07D263/46 ; A61K31/415 ; A61K31/421 ; C07D231/12 ; C07D231/22 ; C07D263/38 ; A61P27/02 ; C07K14/47 ; C12N15/09
Abstract:
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
Public/Granted literature
- US20200157062A1 HETEROCYCLIC COMPOUND Public/Granted day:2020-05-21
Information query
IPC分类:
